** U.S.-listed shares of Israeli drugmaker RDHL.O fall as
much as 33% to a record low of $2.60
** Stock among biggest pct losers on the Nasdaq
Biotechnology Index .NBI
** RDHL says offering 4.7 million American depositary shares
for gross proceeds of $15.5 million Pn5985rWa
** Cantor Fitzgerald sole bookrunner for offering, which is
expected to close on or about Nov. 23
** Each ADS represents 10 ordinary shares
** Including session losses, stock down ~64% YTD
(Reporting by Bhanvi Satija in Bengaluru)
((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))